Gabapentin and Hypercoagulation - a phase IV clinical study of FDA data
Summary:
Hypercoagulation is reported as a side effect among people who take Gabapentin (gabapentin), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Coumadin, and have Multiple sclerosis.
The phase IV clinical study analyzes which people have Hypercoagulation when taking Gabapentin. It is created by eHealthMe based on reports of 313,421 people who have side effects when taking Gabapentin from the FDA, and is updated regularly.
What is Gabapentin?
Gabapentin has active ingredients of gabapentin. It is often used in peripheral neuropathy. eHealthMe is studying from 322,975 Gabapentin users. Check the latest studies of Gabapentin.
What is Hypercoagulation?
Hypercoagulation (increased tendency for clotting of the blood) is found to be associated with 404 drugs and 537 conditions by eHealthMe. Check the latest studies of Hypercoagulation.
313,421 people reported to have side effects when taking Gabapentin.
Among them, 26 people (0.01%) have Hypercoagulation.
Among these 26 people:
How long have people been on Gabapentin when they have Hypercoagulation? *
What is the gender of people who have Hypercoagulation when taking Gabapentin? *
What is the age of people who have Hypercoagulation when taking Gabapentin? *
What are other drugs people take besides Gabapentin? *
What are other side effects people have besides Hypercoagulation? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Gabapentin and have Hypercoagulation?
- Check whether Hypercoagulation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Gabapentin:
- Gabapentin (322,975 reports)
Hypercoagulation treatments and more:
- Hypercoagulation (4,011 reports)
How severe was Hypercoagulation and when was it recovered:
Expand to all the drugs that have ingredients of gabapentin:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Gabapentin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hypercoagulation:
- Hypercoagulation (404 drugs)
Browse all the conditions that are associated with Hypercoagulation:
- Hypercoagulation (537 conditions)
Related publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on gabapentin (the active ingredients of Gabapentin) and Gabapentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Clozapine cause Hyperammonaemia? - now
- Drug interactions of Belbuca and Clopidogrel - 5 seconds ago
- Drug interactions of Arixtra and Meropenem - 6 seconds ago
- Neuroblastoma and Hypothyroidism - 8 seconds ago
- Drug interactions of Effient and Allegra - 8 seconds ago
- Could Xarelto cause Tooth Socket Haemorrhage? - 12 seconds ago
- Cataplexy and Sleep Walking - 12 seconds ago
- Could Nevanac cause Abnormal Behavior? - 16 seconds ago
- Could Rosuvastatin Calcium cause Haemorrhage Subcutaneous? - 19 seconds ago
- Drug interactions of Multivitamin and Ginger Root - 20 seconds ago